Vinva Investment Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2M Buy
+32,237
New +$2.24M 0.02% 285
2025
Q3
Sell
-6,994
Closed -$604K 436
2025
Q2
$604K Buy
+6,994
New +$548K 0.02% 342
2025
Q1
Sell
-13,207
Closed -$1.03M 399
2024
Q4
$1.03M Buy
+13,207
New +$978K 0.04% 288
2024
Q3
Sell
-10,928
Closed -$1.25M 428
2024
Q2
$1.25M Sell
10,928
-3,660
-25% -$463K 0.06% 265
2024
Q1
$2.02M Buy
14,588
+7,000
+92% +$880K 0.11% 206
2023
Q4
$942K Sell
7,588
-2,904
-28% -$297K 0.06% 271
2023
Q3
$1M Sell
10,492
-2,359
-18% -$266K 0.09% 220
2023
Q2
$1.64M Buy
12,851
+2,325
+22% +$281K 0.14% 171
2023
Q1
$1.2M Buy
+10,526
New +$1.18M 0.1% 224

Other funds holding DXCM

Vinva Investment Management's DXCM Position: Q1 2026 in Review

Vinva Investment Management opened a new position in DexCom (DXCM) in Q1 2026: 32,237 shares worth $2M. The stake represents 0.02% of the portfolio and ranks #285 among its holdings. This is a return to the name: Vinva Investment Management previously reported a position in DXCM as recently as Q2 2025.

Vinva Investment Management first reported a position in DXCM in Q1 2023 and has held it in 9 quarters since. The position peaked at $2.02M in Q1 2024. 959 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Vinva Investment Management held 32,237 shares of DexCom worth $2M as of Q1 2026.
  • DexCom was a new Vinva Investment Management position in Q1 2026.
  • DexCom made up 0.02% of Vinva Investment Management's portfolio in Q1 2026, its #285 holding.
  • Vinva Investment Management first reported a position in DexCom in Q1 2023 and has held it in 9 quarters since.
  • Vinva Investment Management's DexCom position peaked at $2.02M in Q1 2024.
  • 959 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Vinva Investment Management's 13F filing for Q1 2026, filed 14 May 2026.